Effect of Empagliflozin on Body Composition and Ketones

NCT03877406 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Fat; Intolerance, Pancreas

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Hypoglycemics Oral

Sponsor

Seoul National University Bundang Hospital